CD1, a conserved family of major histocompatibility (MHC)-like glycoprotein
s in mammals, specializes in capturing lipid rather than peptide antigen fo
r presentation to T lymphocytes. The principles and mechanisms of this newl
y discovered immune strategy differ markedly from those governing classical
MHC-peptide presentation. They might be exploited for the design of new li
pid-based microbial vaccines and adjuvants.